ADAP - 2 Penny Stocks That Could Make You Rich
Penny stocks, defined as equities that trade at less than $5 a share, are rarely worth the risk. Companies with extremely low share prices tend to have weak balance sheets, an absurdly high number of outstanding shares, few institutional investors, sky-high levels of interest from short-sellers, and a poor near-term outlook. What's more, these types of equities are often used as day-trading vehicles, making them exceptionally volatile in terms of price.
All of that said, there are a select few penny stocks worth buying right now. In fact, these hidden gems may even make their early shareholders rich by the end of the current decade.
Which penny stocks stand apart from the crowd? Adaptimmune Therapeutics plc (NASDAQ: ADAP) and OrganiGram Holdings Inc. (NASDAQ: OGI) are two healthcare stocks that sport jaw-dropping levels of deep value -- most of which is being completely ignored by this moody market right now.